The FDA is getting its hands on a ‘human emulation system,’ and Emulate hopes they never let go
The future for the organs-on-chips industry will depend to a large extent on the FDA’s ability to understand how it works as well as its practical, near-term potential for replacing animals in preclinical research as the system evolves. And now regulators are about to get some hands-on experience with a collaborative effort to build a human emulation system inside the agency.
The FDA has agreed to work with Emulate, a spinoff of the Wyss Institute which has been developing and improving on the industry standard in the field, snagging partnerships with the likes of Merck and J&J. The work will be done under a Cooperative Research and Development Agreement (CRADA), creating a platform for tox testing for products like foods, dietary testing and cosmetics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.